Hill-Rom Holdings - 33 Year Stock Price History | HRC

Historical daily share price chart and data for Hill-Rom Holdings since 1987 adjusted for splits. The latest closing stock price for Hill-Rom Holdings as of September 25, 2020 is 82.05.
  • The all-time high Hill-Rom Holdings stock closing price was 117.57 on July 27, 2020.
  • The Hill-Rom Holdings 52-week high stock price is 117.68, which is 43.4% above the current share price.
  • The Hill-Rom Holdings 52-week low stock price is 72.29, which is 11.9% below the current share price.
  • The average Hill-Rom Holdings stock price for the last 52 weeks is 103.12.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Hill-Rom Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 102.3350 113.7400 117.5700 74.8800 82.0500 -27.73%
2019 103.2166 85.0300 114.0100 83.5800 113.5300 28.21%
2018 89.7918 84.6400 98.8500 79.7300 88.5500 5.05%
2017 74.3231 56.8400 85.3600 56.7600 84.2900 50.14%
2016 52.7120 47.1400 62.4500 43.2900 56.1400 16.81%
2015 51.2033 45.2700 57.7900 45.1300 48.0600 5.35%
2014 40.9810 40.9800 46.5100 35.1300 45.6200 10.35%
2013 35.9157 29.6000 42.2400 29.6000 41.3400 45.05%
2012 30.5271 34.2800 35.9600 25.3000 28.5000 -15.41%
2011 37.3400 39.8300 47.4800 27.3700 33.6900 -14.43%
2010 32.0370 24.4300 43.6200 23.3700 39.3700 64.11%
2009 17.0006 16.9500 24.1800 8.8900 23.9900 45.75%
2008 26.7492 29.8387 33.4600 15.6400 16.4600 -45.06%
2007 31.8820 30.4839 36.2849 28.0108 29.9624 -2.11%
2006 28.7452 26.6237 33.1129 25.4086 30.6075 15.22%
2005 27.5499 29.4624 30.5860 24.1935 26.5645 -11.04%
2004 31.5994 33.2581 37.7527 25.6452 29.8602 -10.51%
2003 28.5656 28.8011 33.3656 25.2204 33.3656 28.46%
2002 30.1816 29.5914 35.4785 25.2258 25.9731 -12.59%
2001 28.0723 27.6237 31.2366 23.5914 29.7151 7.32%
2000 19.6275 16.8333 29.9086 15.6237 27.6882 62.51%
1999 21.0981 29.8387 29.8387 14.1828 17.0376 -44.29%
1998 31.0729 27.1505 34.6129 26.0753 30.5806 11.12%
1997 23.5798 19.2903 27.5215 19.2903 27.5215 41.21%
1996 19.1341 18.2796 21.5054 17.2043 19.4892 6.99%
1995 16.0471 15.2581 18.2151 14.5860 18.2151 22.09%
1994 18.4549 22.3817 23.2527 14.4516 14.9194 -33.34%
1993 22.6914 21.3065 26.0753 19.6935 22.3817 5.39%
1992 20.7991 18.0108 23.3226 18.0108 21.2366 12.06%
1991 13.0438 10.3145 18.9516 10.1801 18.9516 85.53%
1990 11.0259 11.8952 12.9032 8.5027 10.2151 -13.14%
1989 9.2741 7.8952 11.9946 7.1586 11.7608 42.83%
1988 8.1872 6.6855 9.5780 6.3522 8.2339 23.76%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $5.465B $2.907B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $183.161B 34.37
Medtronic (MDT) Ireland $138.669B 26.12
Stryker (SYK) United States $76.844B 29.80
Boston Scientific (BSX) United States $53.421B 30.86
Lonza Group Ag (LZAGY) Switzerland $45.798B 0.00
Baxter (BAX) United States $40.316B 0.00
Terumo (TRUMY) Japan $30.009B 38.36
Zimmer Biomet Holdings (ZBH) United States $27.960B 23.20
EssilorLuxottica Societe Anonyme (ESLOY) France $27.740B 0.00
ResMed (RMD) United States $24.494B 35.51
Sunny Optical Technology (SNPTF) China $16.508B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.353B 0.00
Bio-Rad Laboratories (BIO) United States $14.962B 67.67
Insulet (PODD) United States $14.703B 622.11
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.255B 43.73
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.174B 10.60
Canopy Growth (CGC) Canada $5.268B 0.00
Haemonetics (HAE) United States $4.417B 29.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.388B 0.00
Neogen (NEOG) United States $3.998B 65.56
ICU Medical (ICUI) United States $3.904B 29.79
Envista Holdings (NVST) United States $3.806B 25.96
Abcam (ABCZY) $3.251B 0.00
TG Therapeutics (TGTX) United States $3.131B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.118B 0.00
National Vision Holdings (EYE) United States $2.964B 460.63
NuVasive (NUVA) United States $2.522B 35.15
Agios Pharmaceuticals (AGIO) United States $2.380B 0.00
AtriCure (ATRC) United States $1.800B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.692B 0.00
NanoString Technologies (NSTG) United States $1.660B 0.00
Cardiovascular Systems (CSII) United States $1.446B 0.00
MacroGenics (MGNX) United States $1.355B 0.00
Owens & Minor (OMI) United States $1.299B 29.09
Aphria (APHA) Canada $1.221B 0.00
InMode (INMD) Israel $1.154B 29.10
Cerus (CERS) United States $1.010B 0.00
Quanterix (QTRX) United States $0.932B 0.00
PetIQ (PETQ) United States $0.912B 26.16
BioLife Solutions (BLFS) United States $0.840B 437.50
Lantheus Holdings (LNTH) United States $0.815B 11.30
OraSure Technologies (OSUR) United States $0.804B 0.00
Phibro Animal Health (PAHC) United States $0.722B 16.52
Meridian Bioscience (VIVO) United States $0.707B 16.34
LeMaitre Vascular (LMAT) United States $0.687B 41.95
Vapotherm (VAPO) United States $0.642B 0.00
Aurora Cannabis (ACB) Canada $0.583B 0.00
Zynex (ZYXI) United States $0.580B 50.61
Eagle Pharmaceuticals (EGRX) United States $0.566B 80.02
Omeros (OMER) United States $0.551B 0.00
Surmodics (SRDX) United States $0.522B 57.22
VAREX IMAGING (VREX) United States $0.472B 20.46
Viemed Healthcare (VMD) United States $0.341B 12.19
Cytosorbents (CTSO) United States $0.340B 0.00
HEXO (HEXO) $0.318B 0.00
Utah Medical Products (UTMD) United States $0.295B 25.34
Surface Oncology (SURF) United States $0.252B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.241B 0.00
Organigram Holdings (OGI) Canada $0.204B 0.00
Female Health (VERU) United States $0.180B 0.00
Wound Management Technologies (SMTI) United States $0.164B 0.00
Chimerix (CMRX) United States $0.163B 0.00
Bovie Medical (APYX) United States $0.163B 0.00
Fonar (FONR) United States $0.141B 12.46
Exagen (XGN) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) United States $0.133B 0.00
Evolus (EOLS) United States $0.130B 0.00
Capricor Therapeutics (CAPR) United States $0.105B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.084B 0.00
Rockwell Medical (RMTI) United States $0.075B 0.00
United-Guardian (UG) United States $0.069B 15.40
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Brainsway (BWAY) Israel $0.063B 0.00
Nephros (NEPH) United States $0.058B 0.00
MTech Acquisition (KERN) United States $0.051B 0.00
Trinity Biotech (TRIB) Ireland $0.048B 9.09
ImmuCell (ICCC) United States $0.040B 0.00
FSD PHARMA INC (HUGE) Canada $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.019B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.018B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
NF Energy Saving (BIMI) China $0.017B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Senestech (SNES) United States $0.005B 0.00